EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms

Xixi Hou, Mengmeng Huang, Qingqing Zhang iD, Qiyan Yao iD, Jianxue Yang

RSC Advances · 2026 · 16 (38) · 42765-42777

DOI: 10.1039/d6ra04127b ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Xixi Hou und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology Luoyang 471003 China Docyix1969@126.com. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dolutegravir derivatives bearing 1,2,3-triazole moieties 3b and 3i exhibited potent antiproliferative activity against HepG2 cells.

Autor:innen und Institutionen

  • The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology Luoyang 471003 China Docyix1969@126.com.
  • College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology 263 Kaiyuan Road Luoyang 471003 China yaoqiyan66@126.com.

ORCID-Profile: Qingqing Zhang, Qiyan Yao

Zitieren

APA

Hou, X., Huang, M., Zhang, Q., Yao, Q., & Yang, J. (2026). Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms. RSC Advances, 16(38), 42765-42777. https://doi.org/10.1039/d6ra04127b

Vancouver

Hou X, Huang M, Zhang Q, Yao Q, Yang J. Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms. RSC Advances. 2026;16(38):42765-42777. doi:10.1039/d6ra04127b

BibTeX
@article{Hou2026,
  author = {Hou, Xixi and Huang, Mengmeng and Zhang, Qingqing and Yao, Qiyan and Yang, Jianxue},
  title = {Synthesis and in vitro antiproliferative activity of dolutegravir derivatives against hepatocellular carcinoma via apoptosis-related mechanisms},
  journal = {RSC Advances},
  year = {2026},
  volume = {16},
  number = {38},
  pages = {42765--42777},
  doi = {10.1039/d6ra04127b}
}
Kostenlos starten →